AHA taps state advocate as new CEO
Steve Walsh, the CEO of a Massachusetts hospital group, will assume the top role in the early fall, after the AHA’s longtime leader retires.
Top FDA gene and cell therapy regulator to step down
Following Vijay Kumar’s exit, acting CBER Director Karim Mikhail will also oversee a review office that has become a battleground for debates on FDA flexibility.
Nearly 4M Medicare beneficiaries could access GLP-1s for weight loss under new program: analysis
Millions could meet criteria to receive GLP-1s, which could cost Medicare billions of dollars, according to a report by KFF.